Clinical Trial

Anabolic Therapy in Postmenopausal Osteoporosis

Active, Not Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
In this research study we want to learn more about the effect of two different FDA-approved medications in the treatment of osteoporosis.
Protocol Amendment History 6 amendments
This ClinicalTrials.gov record has been amended 6 times since 2021-08-12; most recent amendment 2026-04-14.
Status change: Recruiting → Active, Not Recruiting 2023-05-11
Status change: Not Yet Recruiting → Recruiting 2022-03-21
Trial Details
NCT Number NCT05010590
Lead Sponsor Massachusetts General Hospital
Conditions Postmenopausal Osteoporosis
Enrollment 50 participants
Start Date 2022-03-24
Primary Completion 2027-10-01 (estimated)
Study Completion 2027-11-01 (estimated)
Updated on ClinicalTrials.gov 2026-04-15